臨床研究および検査研究の記録

  • ISSN: 2386-5180
  • ジャーナル h-index: 17
  • 雑誌引用スコア: 6.26
  • ジャーナルのインパクトファクター: 5.31
インデックス付き
  • Genamics JournalSeek
  • 中国国家知識基盤 (CNKI)
  • サイテファクター
  • 研究ジャーナル索引作成ディレクトリ (DRJI)
  • パブロン
  • ユーロパブ
  • Google スカラー
  • シェルパ・ロメオ
  • 秘密検索エンジン研究所
このページをシェアする

抽象的な

Determination of Adherence to Treatment of Schizophrenia Patients in Turkey

Funda Kavak

Aim and purpose: The purpose of this study is to determine the adherence to treatment of schizophrenic patients.

Method: This research was done as a descriptive. Research in eastern Turkey in a psychiatric clinic was conducted between September 2017 - February 2018 date. The study′s universe constituted 1500 psychiatric patients who were treated in a psychiatric clinic. The sample size was determined as 196 with a power analysis. The names of the patients were listed and selected by simple random sampling method. For the collection of data in the study, descriptive trait form and Morisky Therapy Compliance Scale were used.

Results and Discussion: In the study, 43.9% of the patients were in the age range of 29-39 years, 79.1% were male, 62.2% were secondary school graduates, 59.7 were single, 80.1% were not working, 68% family history of mental illness. In the study, the difference between the gender and Morisky adherence to treatment scale total score was statistically significant (p<0.05). In the study, it was found that the statistically significant difference was found between the education level of the patients and morisky adherence to treatment scale total score (p<0.05). It was determined that there was a statistically significant difference between the level of income perception of the patients and the scale total score of morisky treatment (p<0.05).

Conclusion: In the study, it was determined that adherence to treatment of schizophrenia patients is moderate. In addition to medication to increase adherence to treatment of patients, complementary and alternative methods, providing social and moral support, psychosocial skills training, giving therapies may be recommended.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません